WISE s.r.l., a Milan, Italy- and Berlin, Germany-based medical device company, raised €1m in equity financing.
Backers included High-Tech Gründerfonds, Atlante Seeds and b-to-v Partners, which joined existing investor Agite!.
The company intends to use the funds to finalize the prototype and engage into pre-clinical development of its first product aimed at the spinal cord stimulation market.
Founded in 2011 by CEO Dr. Luca Ravagnan, Wise (Wiringless Implantable Stretchable Electronics) is developing implantable neurostimulation devices based on their and proprietary technology platform developed at the University of Milan, which allows for the insertion of electronic microcircuits in biocompatible silicones.
Based on this technology, the company is able to generate elastic electrodes that resist stretching and twisting without the risk of dislocation or electrical failure. The platform can also be used for various other fields and applications, e.g. consumer electronics.
FinSMEs
08/11/2013